Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 2/20 | 0.32 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.32 |
| ▸ | BACE1 | P56817 | 1/20 | 0.32 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.32 |
| ▸ | PIM1 | P11309 | 1/20 | 0.32 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.32 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.32 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.32 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.32 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.31 |
| ▸ | HPSE | Q9Y251 | 2/20 | 0.31 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26168710 | 0.97 | KDM4E (0.33) | PLA2G2APLA2G4ABACE1PIM1CSNK2A2 | |
| SCHEMBL26169014 | 0.96 | PLA2G2A (0.33) | PLA2G2APLA2G4APDE10APIM1CSNK2A2 | |
| SCHEMBL26168783 | 0.96 | PLA2G2A (0.33) | PLA2G2APLA2G4APDE10APIM1CSNK2A2 | |
| SCHEMBL26168704 | 0.96 | KDM4E (0.34) | PLA2G2APLA2G4ABACE1PIM1CSNK2A2 | |
| SCHEMBL23057996 | 0.96 | PLA2G2A (0.33) | PLA2G2APLA2G4ABACE1PDE10APIM1 | |
| SCHEMBL26168514 | 0.96 | PLA2G2A (0.33) | PLA2G2APLA2G4APDE10APIM1CSNK2A2 | |
| SCHEMBL26169219 | 0.96 | PLA2G2A (0.33) | PLA2G2APLA2G4APDE10APIM1CSNK2A2 | |
| SCHEMBL26168709 | 0.95 | PLA2G2A (0.33) | PLA2G2APLA2G4ABACE1PIM1CSNK2A2 | |
| SCHEMBL26168718 | 0.95 | PLA2G2A (0.33) | PLA2G2APLA2G4ABACE1PIM1CSNK2A2 | |
| SCHEMBL26168712 | 0.95 | KDM4E (0.33) | PLA2G2APLA2G4ABACE1PIM1CSNK2A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230172062-A1 | ORGANIC ELECTROLUMINESCENT APPARATUS | MERCK PATENT GMBH (DE) | 2023-06-01 | — | — | US | disclosed |
| US-20230172062-A1 | ORGANIC ELECTROLUMINESCENT APPARATUS | MERCK PATENT GMBH (DE) | 2023-06-01 | — | — | US | disclosed |
| WO-2021180614-A1 | ORGANIC ELECTROLUMINESCENT APPARATUS | MERCK PATENT GMBH (DE) | 2021-09-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230172062-A1 | ORGANIC ELECTROLUMINESCENT APPARATUS | SLC29A1, SLC19A2, NUDT1 | PLA2G2A 4486/4885PLA2G4A 4769/4885BACE1 4451/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.